<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheng Q</submitter><funding>The Science and Technology Develoment Fund of Macau SAR:</funding><funding>National Natural Science Foundation of China</funding><funding>Science Foundation Project in Sichuan Province</funding><funding>Innovation Team and Talents Cultivation Program of National Chinese Medicine</funding><funding>Postdoctoral Fellowship Program of CPSF</funding><pagination>e2500446</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12506840</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(26)</volume><pubmed_abstract>Achieving direct delivery of drugs to the tumor site is a prerequisite for successful drug development, necessitating that drug molecules be cell permeable. Numerous studies have shown that cell-penetrating peptides (CPPs) can augment the efficacy of various therapeutic agents by enhancing cellular uptake, prompting their advancement into preclinical studies. However, the non-specificity and cationic properties of CPPs impede their clinical application. Attributed to the easily accessible capacity and excellent biocompatibility of red blood cells (RBC), herein, an RBC membrane camouflaged, cell-penetrating peptides R8-(RRRRRRRR)based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), thus precisely inducing tum</pubmed_abstract><journal>Advanced healthcare materials</journal><pubmed_title>RBC Membrane-Camouflaged Nanosystem-Mediated Synergistic Drug Combination for Enhanced Anti-Tumor Therapy.</pubmed_title><pmcid>PMC12506840</pmcid><funding_grant_id>81973662</funding_grant_id><funding_grant_id>23ZYZYTS0420</funding_grant_id><funding_grant_id>0047/2023/AMJ</funding_grant_id><funding_grant_id>GZB20230093</funding_grant_id><funding_grant_id>ZYYCXTD-D-202209</funding_grant_id><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Cheng Q</pubmed_authors><pubmed_authors>Luo M</pubmed_authors><pubmed_authors>He X</pubmed_authors><pubmed_authors>Zhong X</pubmed_authors><pubmed_authors>Deng L</pubmed_authors></additional><is_claimable>false</is_claimable><name>RBC Membrane-Camouflaged Nanosystem-Mediated Synergistic Drug Combination for Enhanced Anti-Tumor Therapy.</name><description>Achieving direct delivery of drugs to the tumor site is a prerequisite for successful drug development, necessitating that drug molecules be cell permeable. Numerous studies have shown that cell-penetrating peptides (CPPs) can augment the efficacy of various therapeutic agents by enhancing cellular uptake, prompting their advancement into preclinical studies. However, the non-specificity and cationic properties of CPPs impede their clinical application. Attributed to the easily accessible capacity and excellent biocompatibility of red blood cells (RBC), herein, an RBC membrane camouflaged, cell-penetrating peptides R8-(RRRRRRRR)based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), thus precisely inducing tum</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T08:59:01.664Z</modification><creation>2026-05-07T03:12:43.985Z</creation></dates><accession>S-EPMC12506840</accession><cross_references><pubmed>40331462</pubmed><doi>10.1002/adhm.202500446</doi></cross_references></HashMap>